Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChronoFOLFOX plus Avastin in metastatic colorectal cancer
NCT00385021Phase 2Terminated
- Sponsor
- City of Hope Tulsa
- Start
- Oct 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of bevacizumab in colorectal cancer (CRC), sponsored by City of Hope Tulsa. Started Oct 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00385021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385021.